|4Sep 1, 1:44 PM ET

CYNOSURE INC 4

4 · CYNOSURE INC · Filed Sep 1, 2016

Insider Transaction Report

Form 4
Period: 2016-08-30
Transactions
  • Sale

    Class A Common Stock

    2016-08-30$51.66/sh5,000$258,3030 total
  • Exercise/Conversion

    Class A Common Stock

    2016-08-30$11.94/sh+5,000$59,7005,000 total
  • Exercise/Conversion

    Director Stock Option (right to buy)

    2016-08-305,0000 total
    Exercise: $11.94Exp: 2021-06-03Class A Common Stock (5,000 underlying)
  • Exercise/Conversion

    Director Stock Option (right to buy)

    2016-08-308,0000 total
    Exercise: $21.16Exp: 2022-05-09Class A Common Stock (8,000 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2016-08-30$21.16/sh+8,000$169,2808,000 total
  • Sale

    Class A Common Stock

    2016-08-30$51.66/sh8,000$413,2850 total
  • Exercise/Conversion

    Class A Common Stock

    2016-08-30$23.45/sh+8,000$187,6008,000 total
  • Exercise/Conversion

    Director Stock Option (right to buy)

    2016-08-308,0000 total
    Exercise: $23.45Exp: 2023-06-24Class A Common Stock (8,000 underlying)
  • Sale

    Class A Common Stock

    2016-08-30$51.66/sh8,000$413,2850 total
Footnotes (4)
  • [F1]The sales price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $51.22 to $52.14 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F2]The option became exercisable as to approximately 33.33% of the shares on each one-year anniversary of the 6/3/2011 grant date.
  • [F3]The option became exercisable as to 100% of the shares on the one-year anniversary of the 5/9/2012 grant date.
  • [F4]The option became exercisable as to 100% of the shares on the one-year anniversary of the 6/24/2013 grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION